Global Cell Therapy Growth Factors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Cell Therapy Growth Factors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Cell therapy growth factors are signaling molecules that play a crucial role in regulating various cellular processes, including cell growth, proliferation, differentiation, and tissue repair. These growth factors are naturally occurring proteins that are produced by cells in the body and act as messengers to communicate instructions for cellular activities. In the context of cell therapy, growth factors are often used to enhance the therapeutic potential of cell-based treatments by influencing cellular behavior and tissue regeneration.
Cell Therapy Growth Factors report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cell Therapy Growth Factors market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Cell Transplantation and Regenerative Medicine are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cell Therapy Growth Factors industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Cell Therapy Growth Factors key manufacturers include Thermo Fisher Scientific, PeproTech, Bio-Techne, STEMCELL Technologies, BD Biosciences, Merck (Sigma-Aldrich), Sartorius, BioLegend and ProSpec-Tany TechnoGene, etc. Thermo Fisher Scientific, PeproTech, Bio-Techne are top 3 players and held % sales share in total in 2022.
Cell Therapy Growth Factors can be divided into Platelet-Derived Growth Factor (PDGF), Fibroblast Growth Factor (FGF), Transforming Growth Factor-Beta (TGF-β) and Vascular Endothelial Growth Factor (VEGF), etc. Platelet-Derived Growth Factor (PDGF) is the mainstream product in the market, accounting for % sales share globally in 2022.
Cell Therapy Growth Factors is widely used in various fields, such as Cell Transplantation, Regenerative Medicine, Tissue Engineering and Others, etc. Cell Transplantation provides greatest supports to the Cell Therapy Growth Factors industry development. In 2022, global % sales of Cell Therapy Growth Factors went into Cell Transplantation filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cell Therapy Growth Factors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Thermo Fisher Scientific
PeproTech
Bio-Techne
STEMCELL Technologies
BD Biosciences
Merck (Sigma-Aldrich)
Sartorius
BioLegend
ProSpec-Tany TechnoGene
Lonza
Sino Biological
GE Healthcare
ACROBiosystems
Core Biogenesis
Proteintech
Segment by Type
Platelet-Derived Growth Factor (PDGF)
Fibroblast Growth Factor (FGF)
Transforming Growth Factor-Beta (TGF-β)
Vascular Endothelial Growth Factor (VEGF)
Nerve Growth Factor (NGF)
Others
Cell Transplantation
Regenerative Medicine
Tissue Engineering
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cell Therapy Growth Factors market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cell Therapy Growth Factors, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cell Therapy Growth Factors industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Cell Therapy Growth Factors in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cell Therapy Growth Factors introduction, etc. Cell Therapy Growth Factors Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Cell Therapy Growth Factors market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Cell Therapy Growth Factors report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cell Therapy Growth Factors market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Cell Transplantation and Regenerative Medicine are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cell Therapy Growth Factors industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Cell Therapy Growth Factors key manufacturers include Thermo Fisher Scientific, PeproTech, Bio-Techne, STEMCELL Technologies, BD Biosciences, Merck (Sigma-Aldrich), Sartorius, BioLegend and ProSpec-Tany TechnoGene, etc. Thermo Fisher Scientific, PeproTech, Bio-Techne are top 3 players and held % sales share in total in 2022.
Cell Therapy Growth Factors can be divided into Platelet-Derived Growth Factor (PDGF), Fibroblast Growth Factor (FGF), Transforming Growth Factor-Beta (TGF-β) and Vascular Endothelial Growth Factor (VEGF), etc. Platelet-Derived Growth Factor (PDGF) is the mainstream product in the market, accounting for % sales share globally in 2022.
Cell Therapy Growth Factors is widely used in various fields, such as Cell Transplantation, Regenerative Medicine, Tissue Engineering and Others, etc. Cell Transplantation provides greatest supports to the Cell Therapy Growth Factors industry development. In 2022, global % sales of Cell Therapy Growth Factors went into Cell Transplantation filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cell Therapy Growth Factors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Thermo Fisher Scientific
PeproTech
Bio-Techne
STEMCELL Technologies
BD Biosciences
Merck (Sigma-Aldrich)
Sartorius
BioLegend
ProSpec-Tany TechnoGene
Lonza
Sino Biological
GE Healthcare
ACROBiosystems
Core Biogenesis
Proteintech
Segment by Type
Platelet-Derived Growth Factor (PDGF)
Fibroblast Growth Factor (FGF)
Transforming Growth Factor-Beta (TGF-β)
Vascular Endothelial Growth Factor (VEGF)
Nerve Growth Factor (NGF)
Others
Segment by Application
Cell Transplantation
Regenerative Medicine
Tissue Engineering
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cell Therapy Growth Factors market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cell Therapy Growth Factors, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cell Therapy Growth Factors industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Cell Therapy Growth Factors in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cell Therapy Growth Factors introduction, etc. Cell Therapy Growth Factors Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Cell Therapy Growth Factors market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
